Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Iterum Therapeutics plc (in Provisional Liquidation) filed a petition in the High Court in Ireland to wind up the company. An order appointed Damien Murran and Jennifer McMahon of Teneo Restructuring (Ireland) Limited as joint provisional liquidators.
The petition is due to be heard on April 13, 2026. If a winding up order is made, the joint provisional liquidators will be confirmed as joint liquidators, leading to winding up and, ultimately, dissolution. The provisional liquidators were also appointed to Iterum’s Irish subsidiary, Iterum Therapeutics International Limited (in Provisional Liquidation).
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026